The Oncology Institute, Inc. (TOI)
Largest Insider Buys in Sector
TOI Stock Price History Chart
TOI Stock Performance
About The Oncology Institute, Inc.
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The …
Insider Activity of The Oncology Institute, Inc.
Over the last 12 months, insiders at The Oncology Institute, Inc. have bought $50,000 and sold $173,697 worth of The Oncology Institute, Inc. stock.
On average, over the past 5 years, insiders at The Oncology Institute, Inc. have bought $91,556 and sold $8.02M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Hively Brad (director) — $50,000.
The last purchase of 50,000 shares for transaction amount of $7,500 was made by Hively Brad (director) on 2024‑12‑02.
List of Insider Buy and Sell Transactions, The Oncology Institute, Inc.
| 2024-12-02 | director | 50,000 0.065% | $0.15 | $7,500 | +35.05% | |||
| 2024-11-26 | director | 250,000 0.3151% | $0.17 | $42,500 | +18.57% | |||
| 2024-01-29 | Sale | 10 percent owner | 8,637 0.0114% | $2.12 | $18,310 | -77.47% | ||
| 2024-01-26 | Sale | 10 percent owner | 6,979 0.0096% | $2.14 | $14,935 | -76.64% | ||
| 2024-01-25 | Sale | 10 percent owner | 11,882 0.0161% | $2.07 | $24,596 | -76.18% | ||
| 2024-01-24 | Sale | 10 percent owner | 24,915 0.0356% | $2.30 | $57,305 | -77.56% | ||
| 2024-01-23 | Sale | 10 percent owner | 5,338 0.0071% | $2.11 | $11,263 | -77.22% | ||
| 2024-01-22 | Sale | 10 percent owner | 10,263 0.0139% | $2.12 | $21,758 | -76.90% | ||
| 2024-01-19 | Sale | 10 percent owner | 11,986 0.0161% | $2.13 | $25,530 | -77.33% | ||
| 2023-12-14 | Chief Financial Officer | 100,000 0.1345% | $1.27 | $126,989 | -55.82% | |||
| 2023-11-17 | Sale | director | 25,000 0.0338% | $2.24 | $56,000 | -49.33% | ||
| 2023-11-13 | Sale | director | 47,000 0.0642% | $2.52 | $118,581 | -54.94% | ||
| 2023-03-17 | director | 50,000 0.0778% | $0.55 | $27,495 | +166.88% | |||
| 2023-03-17 | director | 27,854 0.0434% | $0.55 | $15,319 | +166.88% | |||
| 2022-12-16 | Chief Operating Officer | 73,684 0.1093% | $0.95 | $70,000 | +30.68% | |||
| 2022-11-15 | Sale | Chief Executive Officer | 9,718 0.0133% | $2.03 | $19,706 | -49.51% | ||
| 2022-11-15 | Sale | President | 3,767 0.0051% | $2.03 | $7,639 | -49.51% | ||
| 2022-11-15 | Sale | Chief Operating Officer | 577 0.0008% | $2.03 | $1,170 | -49.51% | ||
| 2022-11-15 | Sale | Chief Medical Officer | 199 0.0003% | $2.03 | $404 | -49.51% | ||
| 2022-11-15 | Sale | Chief Accounting Officer | 190 0.0003% | $2.03 | $385 | -49.51% |
Insider Historical Profitability
| Hively Brad | director | 666753 0.8824% | $0.27 | 2 | 3 | |
| Shah Mihir | Chief Financial Officer | 328122 0.4343% | $0.27 | 1 | 0 | |
| BARASCH RICHARD A | director | 235047 0.3111% | $0.27 | 5 | 0 | +59.53% |
| Miller Matthew P | Chief Operating Officer | 175325 0.232% | $0.27 | 1 | 1 | +30.68% |
Institutional Investor Ownership
| Fidelity Investments | $7.51M | 6.39 | 4.75M | -0.01% | -$845.30 | <0.01 | |
| Deerfield Management | $5.31M | 4.51 | 3.36M | 0% | +$0 | 0.01 | |
| The Vanguard Group | $2.82M | 2.4 | 1.78M | +0.34% | +$9,576.38 | <0.0001 | |
| Balyasny Asset Management Llc | $2.73M | 2.32 | 1.73M | +37.71% | +$746,589.51 | 0.01 | |
| Kent Lake Capital LLC | $1.88M | 1.59 | 1.19M | +9.36% | +$160,436.40 | 0.85 |